Medical devices, healthcare technology and the business of care
PMA approval · P900056

ROTABLATOR(R)

Boston Scientific Corp · Decision date May 28, 1993

FDA DECISIONP900056

What did the FDA approve?

FDA records P900056 as an original PMA application. The recorded decision is approval, dated May 28, 1993.

An approval order statement is not included in the imported record. Open the FDA listing for the decision documents.

Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
May 28, 1993

FDA source record

Regulatory record facts

Identifier
P900056
Regulatory pathway
Premarket approval application
Product code
MCX
Decision code
APPR
Decision date
May 28, 1993
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: CATHETER, CORONARY, ATHERECTOMY.

Product code
MCX
FDA device class
3

FDA decision timeline

  1. P900056 received

    Application receipt date recorded by FDA.

  2. P900056 · FDA decision

    APPR

  3. P900056/S228 · Related supplement

    ROTAPRO Rotational Atherectomy System

  4. P900056/S226 · Related supplement

    ROTAPRO Rotational Atherectomy Systems

  5. P900056/S229 · Related supplement

    ROTAPRO Rotational Atherectomy System

Timeline entries are records held by MedtechLedger for P900056. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P900056

Product / regulatory recordCompanyPathwayDecision dateSource
Boston Scientific CorpPMA supplementOct 20, 2026FDA
Boston Scientific CorpPMA supplementOct 21, 2026FDA
Boston Scientific CorpPMA supplementOct 21, 2026FDA

Explore the linked device profile

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Boston Scientific Corp

Headquarters
Not reported
FDA applicant address
Two Scimed Pl., Maple Grove, MN, 55311

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records